“The Clean Signal”
A selective ghrelin receptor agonist that stimulates GH release with minimal effect on cortisol or prolactin, widely regarded as one of the cleanest GHRPs available.
Ipamorelin binds to the ghrelin receptor (GHS-R) in the pituitary, triggering a pulse of growth hormone release. Unlike older GHRPs, it does this selectively, without meaningfully raising cortisol, prolactin, or appetite hormones in the process.
It's not FDA-approved for human use and is sold as a research chemical, not a medicine. Any use outside of a lab setting is legally and medically your own responsibility.
There's no clinically established timeline in humans. Any specific week-by-week expectations you see online come from anecdotal reports, not controlled trials.
Its selectivity for the GH pathway looks favorable in existing studies, but long-term human safety data is limited. This is educational information, not medical advice.
Ipamorelin has been studied in a handful of small human trials, mostly around GI motility and growth hormone secretion, alongside a longer track record of animal research. It's more human-studied than many peptides on this list, but still far from the volume of evidence behind an approved drug.
The numbers are only half of it. The Blueprint covers exact dosing per peptide, proven stacks, and step-by-step injection instructions.
The complete peptide reference. 20+ compounds broken down, step-by-step instructions, stack breakdowns, troubleshooting, and a 30% sourcing discount code.
Learn More · $40